Sign in
CompletedNo phase

A Multicenter, Observational, Single Arm Study of the TECNIS Presbyopia-correcting Intraocular Lens

Key facts

Who runs it
Johnson & Johnson Surgical Vision, Inc.
Where
Australia, Austria, France, Germany, India, Netherlands, South Korea, and Spain20 sites in 8 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
307 people enrolled
Started
10 Apr 2024
Ended
30 Jun 2025
Type of study
Observational
Treatments tested
  • Intervention
Record updated
5 June 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patients who are bilaterally implanted with TECNIS PC IOL and are at least 45 days postoperative from their second eye surgery
  • Clear intraocular media
  • Signed informed consent and data protection documentation
  • Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures
  • Ability to understand, read, and write English or the local language in which the informed consent and questionnaires are provided

Who cannot take part

  • Use of systemic or ocular medication that may affect vision
  • Concurrent participation in another clinical trial
  • Acute or chronic disease or condition, ocular trauma or surgery that may confound results
  • Subjects with ongoing adverse events that might impact outcomes during the study
  • Patients with amblyopia, strabismus, nystagmus

This trial has no sites in United States.

It has sites in 8 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Ambispective post-market data collection on visual symptoms, patient satisfaction and surgeon experience with the TECNIS PC IOL.

Treatments tested

  • Intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 June 2026